Skip to content
Open access

Zanthoxylum bungeanum Essential Oil Alleviates Obesity and Dysregulated Lipid Metabolism in Diet-Induced Obese Mice: A Multi-Omics Study Linking Gut Microbiota to Fatty Acid Metabolism

Sep 2026 · Nutrients · Vol 18 · 0 citations · 46 references
Medicine

TL;DR

Preliminary preclinical evidence supports further investigation of ZBO in the context of dietary strategies for alleviating HFD-induced obesity, and suggests that ZBO administration is associated with remodeling of the gut microbiota and correlated changes in fatty acid metabolic pathways.

Abstract

Background: Obesity is a metabolic disorder characterized by excessive lipid accumulation, disrupted fatty acid homeostasis, and gut microbiota dysbiosis. Zanthoxylum bungeanum essential oil (ZBO) is a natural plant volatile oil with diverse bioactivities, but its anti-obesity effects and potential associations remain unclear. Methods: HFD-induced obese (DIO) mice were evaluated to determine the effects of ZBO. Physiological parameters, glucose tolerance, and serum biochemical markers were assessed. Potential correlates were explored using a multi-omics approach, including integrated serum untargeted metabolomics, 16S rRNA gene sequencing, and RT-qPCR analysis of key genes involved in lipid metabolism in the liver and white adipose tissue. Results: ZBO significantly mitigated HFD-induced body weight gain, visceral adiposity, hepatic steatosis, dyslipidemia, and glucose intolerance. Metabolomics indicated that ZBO administration was associated with alterations in the serum metabolic landscape, particularly in pathways related to fatty acid metabolism and AMPK/PPAR-α signaling. Consistently, ZBO treatment was associated with upregulated mRNA expression of lipid-oxidizing genes (AMPK, PPAR-α, CPT1) and downregulated lipogenic genes (SREBP-1c, ACC, FAS, SCD1, LPL). 16S rRNA sequencing suggested that ZBO was associated with increased gut microbial diversity, decreased the Firmicutes/Bacteroidota ratio, and enriched beneficial taxa (e.g., Ligilactobacillus, Alistipes) while suppressing pro-inflammatory genera. Correlation analysis established robust associations between ZBO-modulated microbes and key fatty acid metabolites, particularly acylcarnitines and AMPK/PPAR-α-related intermediates. Conclusions: Collectively, these multi-omics data suggest that ZBO administration is associated with remodeling of the gut microbiota and correlated changes in fatty acid metabolic pathways. These findings provide preliminary preclinical evidence supporting further investigation of ZBO in the context of dietary strategies for alleviating HFD-induced obesity.

Read PDF

Similar papers

Sep 2026

Ganoderma lucidum spore oil ameliorates high-fat-diet-induced hepatic lipid metabolism disorder by modulation of the gut microbiota.

BACKGROUND Obesity is a major global public health challenge. A high-fat diet (HFD) is a key contributing factor, closely associated with gut microbiota dysbiosis. Although immunomodulatory effects of Ganoderma lucidum spore oil (GLSO) have been reported, its role in lipid metabolism disorders and its interaction with...

Jia-Ning Zhang, Yuan-Lan Yang, Xin-Yi Zhou et al. · 0 citations
Nov 2026

A multi-herb botanical formula ameliorates diet-induced non-alcoholic fatty liver disease associated with microbiota-dependent metabolic remodeling in mice.

Non-alcoholic fatty liver disease (NAFLD) is closely associated with gut microbial dysbiosis and metabolic dysfunction, yet effective and sustainable therapeutic options remain limited. Wuqing Decoction (WQT), a multi-herb botanical formula containing Pueraria lobata and other medicinal and edible components, has shown...

Xin-Rui Meng, Fan Wang, Ying Li et al. · 0 citations
Open access Sep 2026

Phocaeicola dorei YGMCC0564 attenuates HFD-induced glycolipid metabolic disorders in association with remodeling of the gut microbiota and bile acid profiles

Background Glycolipid Metabolic Disorders (GLMD) are characterized by imbalances in glucose and lipid homeostasis, often presenting with severe clinical symptoms. Current pharmacotherapies such as orlistat and metformin show clear efficacy but are associated with long-term tolerability concerns. This study aimed to eva...

Zhi-Li He, Ping Chen, Min-Lei Zhao et al. · 0 citations
Open access Sep 2026

Chinese bayberry leaves proanthocyanidins regulate glucose and lipid metabolism associated with the modulation of the gut microbiota-barrier axis

This study investigated how Chinese bayberry leaves proanthocyanidins (BLPs) regulate glucose and lipid metabolism through the gut microbiota-barrier axis. In high-fat diet (HFD)-induced obese mice, BLPs significantly reduced body weight, improved glucose tolerance, and alleviated dyslipidemia. BLPs remodeled the g...

Meng-Ting Wang, Ji-Min Lv, Xin-Yuan Hu et al. · 0 citations
Open access Aug 2026

Agaro-Oligosaccharides Modulate Gut Microbiota to Improve Lipid Metabolism in Obesity Model Rats.

Obesity is a global health concern, prompting extensive research to identify food components with potential anti-obesity properties. Agaro-oligosaccharides (AOS) have been reported to have anti-obesity effects; however, the precise mechanisms underlying these effects, particularly in relation to the gut microbial metab...

Kento Kuramitsu, Y. Kitaura, Koji Karasawa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.